SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

iSERA Lifesciences gets nod to acquire 100% stake in iSERA Biological

21 Apr 2026 Evaluate

iSERA Lifesciences has received approval from Board of Directors for acquisition of equity shares representing up to 100% of the paid-up equity share capital of iSERA Biological, an unlisted public company, comprising up to 1,61,82,800 equity shares of face value Rs 10 each, from the existing shareholders of iSERA Biological, for a total consideration of Rs 78,00,10,960. Upon completion of the said acquisition, iSERA Biological shall become a wholly owned subsidiary of iSERA Lifesciences.

iSERA Lifesciences (Formerly known as Covidh Technologies) is a technology services provider with an established footprint across diverse domains. 

iSERA Lifesciences Share Price

108.13 2.12 (2.00%)
16-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 2198.85
Infosys 1143.30
HCL Tech. 1159.35
Wipro 182.70
Tech Mahindra 1446.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: